Status:
COMPLETED
Non-Invasive Screening for Fetal Aneuploidy
Lead Sponsor:
Sequenom, Inc.
Collaborating Sponsors:
Obstetrix
Conditions:
Down Syndrome
Edwards Syndrome
Eligibility:
FEMALE
18+ years
Brief Summary
The purpose of this study is to determine if a laboratory test developed by the Sequenom Center for Molecular Medicine (SCMM) that uses a new marker found in the mother's blood can better identify pre...
Eligibility Criteria
Inclusion
- Subject is willing to provide written informed consent
- Pregnant female with singleton gestation 18 years of age or older
- Subject agrees to provide a 20 to 30 mL venous blood sample
- Subject is one of the following: A) currently scheduled to undergo an amniocentesis and/or CVS procedure, OR B) currently in the first trimester of pregnancy and planning to undergo an amniocentesis in the second trimester
- Subject will receive results of a genetic analysis that includes evaluation of the fetus for aneuploidy
Exclusion
- Subject lacks the capacity to provide informed consent
- Twins, triplets or other multiple gestation
Key Trial Info
Start Date :
March 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
August 1 2011
Estimated Enrollment :
5000 Patients enrolled
Trial Details
Trial ID
NCT00847990
Start Date
March 1 2009
End Date
August 1 2011
Last Update
September 5 2011
Active Locations (25)
Enter a location and click search to find clinical trials sorted by distance.
1
Desert Good Samaritan Hospital
Mesa, Arizona, United States, 85202
2
Banner Good Samaritan Hospital
Phoenix, Arizona, United States, 85006
3
Phoenix Perinatal Associates, Phoenix Arizona Clinic
Phoenix, Arizona, United States, 85014
4
Obstetric Perinatal Clinic Tucson (WOMB)
Tucson, Arizona, United States, 85712